Trial Profile
Study of radiotherapy dose escalation with Intensity Modulated Radiation Therapy (IMRT) and synchronous Cetuximab for intermediate stage head and neck cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2019
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions
- Acronyms INTENSE
- 16 Aug 2011 New trial record